Medtronic plc

Medtronic plc is a medical technology company registered in Ireland. It develops devices, systems and services for the treatment of chronic diseases and for surgical procedures. Its shares trade on the New York Stock Exchange under the ticker MDT.

The main branches of its portfolio are cardiovascular products (pacemakers, defibrillators, heart valve and arrhythmia treatments), neuroscience products (spine, brain and nervous system therapies and neuromodulation) and medical surgical products (surgical instruments, robotic systems, and respiratory and patient monitoring equipment). The diabetes business was taken public on Nasdaq in March 2026 under the name MiniMed; Medtronic is the majority owner of this company, and the separation process is ongoing.

For medical device companies, product approvals, clinical trial results, hospital spending, reimbursement rules and the supply chain are watched. The MDT page on Lzzo.com presents the price in US dollars; a Turkish lira, euro or pound sterling display can also be selected. The page includes a historical price chart, technical indicators, the source of the data and the time of the last update.